Pharmacological manipulations of serotonin homeostasis in the rat: Monitoring by platelet serotonin level “ex vivo”

1995 ◽  
Vol 31 ◽  
pp. 271-271
Author(s):  
B JERNEJ ◽  
L CICINSAIN ◽  
S PEROVIC ◽  
S ISKRIC ◽  
M BANOVIC
2020 ◽  
Author(s):  
Mo Xian Chen ◽  
Shu Cheng ◽  
Lei Lei ◽  
Chloe U Wallis ◽  
Qiang Liu ◽  
...  

Abstract Background Prenatal exposure to selective serotonin reuptake inhibitor (SSRI), such as fluoxetine (FLX) may increase susceptibility to autism spectrum disorder (ASD). However, findings from published studies on SSRI and ASD are inconsistent. The use of a rodent model can provide a clear indication as to whether prenatal exposure to SSRIs, independent of maternal psychiatric disorders or genetic syndromes, can cause long-term behavioral and ASD-related neurobiological abnormalities in offspring. Methods FLX or normal saline (NS) was administered to pregnant Sprague-Dawley (SD) rats (FLX=30, NS=27) on gestation day 11 till birth. The resulting offspring were assessed in terms of their physical development and behavior, and underwent in vivo magnetic resonance spectroscopy ( MRS) to quantify biochemical alterations in the prefrontal cortex (PFC). Ex vivo measurements of brain serotonin level and a proteomic analysis were also undertaken. Results The offspring (male offspring in particular) of fluoxetine exposed mothers showed delayed physical development, increased anxiety and impaired social interaction. Moreover, down-regulation of 5-HT or SERT expression and up-regulation of TPH levels was observed in the PFC. We also found that prenatal FLX exposure significantly decreased NAA/tCr with 1 H-MRS in the PFC. Finally, a proteomic study revealed sex-dependent differential protein expression. ConclusionsThese findings may have translational importance suggesting that the use of SSRI medication alone in pregnant mothers may result in developmental delay and autistic-like behavior in their offspring. Our results also help to guide the choice of outcome measures in the identification of molecular and developmental mechanisms that may confer vulnerability in ASD.


2017 ◽  
Vol 08 (02) ◽  
pp. 199-203 ◽  
Author(s):  
S. Era Dutta ◽  
Sriniwas Gupta ◽  
M. S. V. K. Raju ◽  
Abhishek Kumar ◽  
Alka Pawar

ABSTRACT Context: Suicide is a disease and a global public health problem. Suicidology has come to become a topic of study for intervention and research. The serotonin (5-hydroxytryptamine [5HT]) system has remained a prime area of investigation. The neurons and platelets display structural and functional similarities. Ninety-nine percent of 5HT is contained in platelets, which shares similar 5HT uptake and release mechanisms with 5HT neurons. Aims: This study aims to study human self-destructive behavior (HSDB). Objectives: Exploring the biological (serotonin levels in platelets) and psychological aspects (impulsivity) of attempted suicide or HSDB. Settings and Design: Thirty-one patients, above the age of 18 years, with a recent history of HSDB, were studied and given an International Classification of Diseases-10 diagnosis, after a detailed interview. Subjects and Methods: For the platelet 5HT estimation, blood samples were collected, and enzyme immunometric assay carried out. Detailed assessment of the impulsivity was done by the 25-item structured diagnostic interview for borderlines by Zanarini et al. Statistical Analysis Used: We obtained both categorical and continuous data. Chi-square test, Fisher's test, Student's t-test, and Pearson's product moment correlation were used. Results: Female subjects outnumbered males by 2:1. Major depression, adjustment disorder, personality disorder were predominant diagnoses. The mean platelet serotonin concentration for males = 57.3 ng/ml, that of females = 56.05 ng/ml (P > 0.05). Platelet 5HT levels were found to be negatively correlated with impulsivity scores (P < 0.05). Conclusions: Platelet serotonin levels in our study sample were quite low when compared with those reported in published literature. Low serotonin levels were inversely related to impulsivity, but only in males.


2013 ◽  
Vol 40 (8) ◽  
pp. 1360-1366 ◽  
Author(s):  
Helena Šarac ◽  
Jasenka Markeljević ◽  
Viktorija Erdeljić ◽  
Zeljka Josipović-Jelić ◽  
Sanja Hajnšek ◽  
...  

Objective.To examine differences in number and size of signal hyperintensities (SH) on magnetic resonance imaging (MRI) between patients with primary Sjögren syndrome (pSS) and controls who all had frequent episodic tension-type headache (FETH), and to investigate their relation to platelet serotonin level (PSL), patient age, disease duration, and activity.Methods.SH in 22 pSS patients with FETH were compared to 20 aged-matched controls with FETH, using the modified semiquantitative rating scale. Spectrofluorimetry was used for determination of PSL, and the European League Against Rheumatism SS Disease Activity Index (ESSDAI) for disease activity assessment.Results.Statistically significant differences in the total number of SH were noted infratentorially (p = 0.025) and in the basal ganglia for lesions of diameter > 5 mm (p = 0.048). Significant correlations were found between disease duration and number of overall lesions > 5 mm (p = 0.04) and subcortical lesions of diameter 2–5 mm (p = 0.035). Number of periventricular SH inversely correlated to PSL (p = 0.019) and to patient age (p = 0.004), without association with markers of immunoinflammation and ESSDAI.Conclusion.Our study showed that SH on brain MRI are more common in specific regions of the brain in pSS patients with FETH than in controls with FETH, signifying a more widespread cerebral vasculopathy in SS patients with FETH. Periventricular SH seem to be associated to increased platelet serotonin release in pSS patients with FETH and correlated with disease duration, without correlation to the actual ESSDAI and markers of immunoinflammation, and might be linked with chronic immunoinflammation of low-grade intensity and vasculitis in pSS.


1992 ◽  
Vol 37 (3) ◽  
pp. 213-222 ◽  
Author(s):  
Jelka Gabrilovac ◽  
Lipa Čičin-Šain ◽  
Maja Osmak ◽  
Branimir Jernej

PLoS ONE ◽  
2010 ◽  
Vol 5 (10) ◽  
pp. e13346 ◽  
Author(s):  
Luc Dupuis ◽  
Odile Spreux-Varoquaux ◽  
Gilbert Bensimon ◽  
Philippe Jullien ◽  
Lucette Lacomblez ◽  
...  

1990 ◽  
Vol 32 (2) ◽  
pp. 167-174 ◽  
Author(s):  
Branimir Jernej ◽  
Lipa Cicin-Sain

Sign in / Sign up

Export Citation Format

Share Document